Skip to main content
. 2015 Apr 16;97(6):553–558. doi: 10.1002/cpt.115

Figure 2.

Figure 2

Distinct families of cannabinergic ligands. (a) Endo‐ and phytocannabinoids; (b) cannabinoid receptors 1 and 2 (CB1/CB2) agonists; (c) cannabinoid agonists as pharmacological tools; (d) CB2 agonists; (e) CB1 antagonists; and (f) fatty acid amide hydrolase (FAAH) and AEA transport inhibitors.